梅州哪家妇科医院比较便宜梅州激光治疗盆腔炎,梅州打胎手术费要多少钱,梅州慢性宫颈炎怎么引起,梅州急性附件炎好医治吗,梅州霉菌阴道炎与怀孕,梅州盆腔炎的症状和治疗,梅州妊娠2个月流产

BEIJING, Aug. 21 (Xinhuanet) -- The 7th Beijing-Tokyo Forum opened in Beijing on Sunday.This year’s forum, the Future of Asia and China-Japan Cooperation in Economic Reshaping, expects about 600 leaders from the political, business, academic and media fields to take part in a two-day discussion focusing on China-Japan cooperation.Wang Chen, minister of the State Council Information Office, delivers a speech at the reception for Beijing-Tokyo Forum on Saturday night in Beijing.Wang Chen, minister of the State Council Information Office, said at the reception on Saturday for the forum that China pursues an open development that is not exclusive to the rest of the world, but instead ensures cooperation and win-win with other countries."China and Japan’s economy are highly reliant on each other, and they are so close that they cannot get separated from each other,” Wang said.

SYDNEY, July 15 (Xinhua) -- The world's first drug to increase life expectancy of people with advanced melanoma has been approved for use in Australia, local media reported on Friday.The breakthrough drug Yervoy got approval from the Therapeutics Good Association (TGA) on Friday amid hopes it could add two years to the life of people with the most lethal form of skin cancer but for whom other treatments have failed, the Australian Associated Press (AAP) said.Clearance for the drug's use in Australia follows similar approvals by the U.S. health regulator in March.Yervoy works by attacking and destroying cancer cells.Patients are hooked up to an intravenous drip once every three weeks for a total of four doses.Professor Peter Hersey, consultant immunologist to the Melanoma Institute Australia, said no other drug had improved survival rates like Yervoy."Not all patients respond to it but those who do have a good chance of living longer than they would have otherwise," Hersey told AAP.While it may improve survival rates, Yervoy can produce side effects from diarrhea and vomiting to serious blood infections and kidney failure.The average survival time for people with advanced melanoma is just six months.A global study of 676 people with melanoma found that 45 percent of patients given Yervoy were still alive after one year, according to AAP.More than 20 percent lived at least two years, with a small number managing to survive for six years.A separate study, published in June, which showed similarly improved survival rates for patients with newly diagnosed advanced melanoma, has raised hopes that Yervoy could be made more widely available.Melanoma is the fourth most common cancer in Australia, with 10, 300 people diagnosed each year.

RIO DE JANEIRO, Aug. 31 (Xinhua) -- The Brazilian city of Rio de Janeiroe may have an unprecedented dengue fever epidemic next summer, its mayor warned on Wednesday.The increasing number of dengue fever cases in the past few months shows similarities to the months predecing the 2002 and 2008 epidemics, Mayor Eduardo Paes said."Everything points to a new cycle of the disease, certainly the worst epidemic in Rio's history," he said.In 2008, Rio registered some 250,000 cases of dengue fever, with 174 people confirmed dead from the disease. In 2002, Rio had some 290,000 dengue fever cases and 91 people died.In efforts to halt the spread of the disease, Paes has declared a state of alert and is determined to take a series of measures to eliminate the habitat of the Aedes aegypti mosquito, which transmits dengue fever through its bite.Paes also announced an increase in the number of health care units for dengue fever patients. The total cost of a dengue prevention and combat program, which is expected to last until April 2012, will reach 42 million reais (26.25 million U.S. dollars).There is no vaccine against dengue fever, but Brazilian scientists are currently working on one which will immunize against four types of the disease.

BEIJING, Aug. 24 (Xinhuanet) -- Facebook said it is overhauling its privacy settings to give members easier, more precise control over who sees posts, photos and other content over the vast social network.Starting Thursday, Facebook is rolling out new privacy tools that are placed with each piece of content, replacing options that are now buried in overall account settings.Privacy has been a consistently sticky problem for the Palo Alto firm, which has felt the heat from privacy advocates and government regulators. And recently, Facebook faced stiffer competition from Google's new Google+ social network, which was hailed for including a "circles" feature with easy-to-use privacy settings.Instead of vague labels such as "everyone," which have been mistaken for a Facebook member's social network instead of anyone on the Internet, the new system will include more precise words such as "public.""You have told us that 'who can see this?' could be clearer across Facebook, so we have made changes to make this more visual and straightforward," Chris Cox, Facebook's vice president of product, said in blog post."The main change is moving most of your controls from a settings page to being inline, right next to the posts, photos and tags they affect. Plus there are several other updates here that will make it easier to understand who can see your stuff (or your friends') in any context," Cox said.While privacy advocates reserved judgment until the new settings are actually released, they were optimistic the changes will benefit consumers."These changes do make me feel very confident in the direction that Facebook is going and the way they are thinking about privacy," said Erica Newland, policy analyst for the Center for Democracy & Technology in Washington, D.C.

BEIJING, July 26 (Xinhuanet) -- Hong Kong scientists announced that they had determined the idea of time travel is impossible by proving nothing can travel faster than the speed of light.The finding is contained in a study done by a research team from Hong Kong University of Science and Technology. The study was published Monday in a scientific journal "Physical Review Letters" in the United States."The study, which showed that single photons also obey the speed limit c, confirms Einstein's causality, that is, an effect cannot occur before its cause," the university said on its website."By showing that single photons cannot travel faster than the speed of light, our results bring a closure to the debate on the true speed of information carried by a single photon." said Professor Du Shengwang, who led the study.The possibility of time travel was raised 10 years ago when scientists discovered the optical pulses in some specific medium might propagate information in a faster-than-light speed."Our findings will also likely have potential applications by giving scientists a better picture on the transmission of quantum information." Du said.